Earlier this year, the FDA announced premarket approval (PMA) for rhBMP-2 in transforaminal lumbar interbody fusion procedures performed at one or two levels from L2-S1. Specifically, the approval include use with PEEK or titanium interbody cages.

This is a significant change for spine physicians and NASS is currently working on a revision of its BMP-2 coverage recommendations.

To learn more, click here.